Plotnick Michael I MD Boulder, CO - 80303

Plotnick Michael I MD is categorized under Internal Medicine Doctors in Boulder, CO and active since 2010.

Plotnick Michael I MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Michael Plotnick at the company’s single location by writing to 4745 Arapahoe Avenue # 200, Boulder, Colorado CO 80303 or by phoning (303) 938-4710. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Plotnick Michael I MD
Contact Person: Michael Plotnick
Address: 4745 Arapahoe Avenue # 200, Boulder, Colorado 80303
Phone Number: (303) 938-4710
Website Address: bouldermedicalcenter.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Plotnick Michael I MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Michael Plotnick for inquiries that concern Plotnick Michael I MD by calling the company number (303) 938-4710, as your correspondence is most welcome. Additionally, the physical location of the single location of Plotnick Michael I MD can be found at the coordinates 40.01485,-105.23671 as well as the street address 4745 Arapahoe Avenue # 200 in Boulder, Colorado 80303.

For its online presence, you may visit Plotnick Michael I MD’s website at bouldermedicalcenter.com and engage with its social media outlets through on Twitter and on Facebook.